🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess QTc (an interval of the he...
Status
Completed
Location
Lifetree Clinical Research
Start Date
2012-02
Trial ID
NCT01558934
Treatments Being Tested
The primary objective of this study is to assess QTc (an interval of the he...
Status
Completed
Location
Lifetree Clinical Research
Start Date
2012-07
Trial ID
NCT01650649
Treatments Being Tested
The purpose of this Phase 3 open-label treatment study is to evaluate the s...
Status
Completed
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02363998
Treatments Being Tested
The primary objective is to investigate the effects of lofexidine in adults...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2019-09-01
Trial ID
NCT04126083
Treatments Being Tested
A phase II double-blind placebo-controlled parallel group clinical trial th...
Status
Completed
Location
Mountain Manor Treatment Center
Start Date
2020-12-17
Trial ID
NCT04218240
Treatments Being Tested
This is a Phase 1, open-label, parallel-group, single-dose study of lofexid...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2014-06
Trial ID
NCT02318836
Treatments Being Tested
The primary objective of this study is to assess lofexidine related effects...
Status
Completed
Location
Lifetree Clinical Research
Start Date
2013-03
Trial ID
NCT01820442
Treatments Being Tested
A Phase 1, open-label, single-arm study with two single doses of lofexidine...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2015-05
Trial ID
NCT02446002
Treatments Being Tested
This is an open-label pilot trial to evaluate the safety and tolerability o...
Status
Completed
Location
STARS/NYSPI-Columbia University
Start Date
2019-09-01
Trial ID
NCT04056182
Treatments Being Tested
The objective of this single-dose, open-label, randomized, two-period, two-...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2011-10
Trial ID
NCT01437306
Treatments Being Tested